主页文献库搜索
Gene expression and pathologic response to neoadjuvant chemotherapy in breast...

Kolacinska(Agnieszka),Fendler(Wojciech),Sz... Mol Biol Rep 2012-11-23

...PIK3CA, TGFB3, TOP2A, and YWHAZ receptor status of breast cancer core biopsies sampled before neoadjuvant chemotherapy (...

Analysis of the concordance in the EGFR pathway status between primary tumors...

Cejas(P),López-Gómez(M),Aguayo(C),Madero(R... Curr Cancer Drug Targets 2012-07-16

...PIK3CA mutational status and for EGFR, PTEN and pAKT expression, and the number of concordant pairs was 70 (100%), 66 (9...

Clarifying the spectrum of driver oncogene mutations in biomarker-verified sq...

Rekhtman(Natasha),Paik(Paul K),Arcila(Mari... Clin Cancer Res 2012-06-13

...PIK3CA, NRAS, AKT1, ERBB2/HER2, and MAP2K1/MEK1. In addition, all tissue samples from rare patients with the diagnosis o...

[Significance of phosphoinositide 3 kinase/AKT pathway alterations in endomet...

Yang(Xi),Dong(Ying),Zhang(Xiao-ming),Liang... Zhonghua Bing Li Xue Za Zhi 2012-11-08

...PIK3CA mutation was 41.2% (14/34) with a hot mutation spot at T544 in exon 9. PIK3CA mutations more commonly occurred in...

Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and lit...

Liao(Xiaoyun),Morikawa(Teppei),Lochhead(Pa... Clin Cancer Res 2012-08-31

...PIK3CA exon 9 and 20 mutations might confer aggressive tumor behavior.,We sequenced PIK3CA by pyrosequencing in 1,170 re...

BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma amo...

Colombino(M),Sperlongano(P),Izzo(F),Tatang... Cell Death Dis 2012-07-24

Poor data have been previously reported about the mutation rates in K-RAS, BRAF, and PIK3CA genes among patients with he...

Genomic and mutational profiling of ductal carcinomas in situ and matched adj...

Hernandez(Lucia),Wilkerson(Paul M),Lambros... J Pathol 2012-05-22

...PIK3CA mutations restricted to the DCIS component in two cases, and in a third case the frequency of the PIK3CA mutant a...

Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian ta...

Bhattacharya(Bhaskar),Akram(Mohamed),Balas... Cancer Biol Ther 2012-09-19

...PIK3CA were examined by siRNA, and mTOR by rapamycin exposure. Protein expression and apoptosis pre- and post-treatment ...

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant pr...

Pu(Xia),Hildebrandt(Michelle A T),Lu(Charl... Lung Cancer 2011-03-28

...PIK3CA, PTEN, AKT1, AKT2, and FRAP1) of this pathway and identified SNPs associated with development of toxicity and dis...

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expr...

Shima(Kaori),Nosho(Katsuhiko),Baba(Yoshifu... Int J Cancer 2011-02-01

...PIK3CA mutations; and expression of TP53 (p53), CTNNB1 (β-catenin), CDKN1A (p21), CDKN1B (p27), CCND1 (cyclin D1), FASN ...

上一页 238 239 240 241 242 243 244 245 246 下一页 242 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com